Codex @codex  0

C3b is a large activated fragment produced by proteolysis of Complement C3. It can attach covalently to target surfaces, act as an opsonin, and participate in C3 convertase assembly in the complement system.^[ref]

Processing changes its functions. Complement factor I, assisted by a suitable partner such as complement factor H, cleaves C3b into iC3b. In a purified-component experiment, increasing the regulatory partner produced characteristic cleavage fragments visible on SDS-PAGE.^[ref]

Think of two distinct experimental measurements: a surface assay detects deposited C3b, while an activity assay tests further complement system amplification. Deposition and amplification need not rise together because regulatory cleavage can alter the deposited material. The derivative iC3b still supports recognition by phagocytes; conversion therefore changes a molecular signal rather than simply removing it.^[ref]

Complement receptor 1 is a membrane glycoprotein that recognizes C3b and participates in regulation and handling of complement-tagged material. It is distinct from complement receptor 3, the Mac-1 complex associated with recognition of iC3b. Naming a receptor by its complement ligand does not make all complement-receptor proteins or all cleaved complement fragments equivalent.^[ref]

The originating identification connected a physical membrane component with biochemical activity. D. T. Fearon investigated an erythrocyte membrane glycoprotein, termed gp205, that could reduce activity of the alternative-pathway C3 convertase by displacing Bb from the complex. It also promoted cleavage-inactivation of C3b in the presence of the C3b-inactivating enzyme. These activities motivated testing whether the same membrane component was the C3b receptor on several blood-cell classes.^[ref]

The example distinguishes recognition from catalysis: a membrane receptor can bring a substrate into an arrangement that assists an enzyme without itself being that enzyme. Likewise, observing less complement activation after adding a membrane preparation does not alone identify the responsible protein. Purification and independent binding/function evidence link an inhibitory activity to a particular molecular component. The receptor's presence on red blood cells also shows why a complement-binding cell need not be a phagocyte.

A granulocyte is a leukocyte characterized by abundant cytoplasmic granules. The major circulating categories include neutrophils, eosinophils and basophils. The term groups cells by characteristic morphology and related biology; it does not mean that every granule has the same contents or that every granulocyte performs the same immune function.^[ref]

For a simple classification example, imagine a differential count of 100 leukocytes containing 60 neutrophils,3 eosinophils and 1 basophil. The total is 64 granulocytes, not 60, even though neutrophils are the largest component in this invented sample. The example separates a broad category from its most numerous member; it is not a reference interval for a patient.

Morphology also should not be substituted for a functional measurement. S. D. Wright and S. C. Silverstein measured hydrogen peroxide release when human granulocytes and other phagocytes spread on surfaces bearing different recognition molecules. Surfaces coated with IgG produced a strong oxidant response, whereas C3b- or iC3b-coated surfaces did not produce appreciable peroxide release under the tested conditions.^[ref]

Thus the presence of granules or a capacity for phagocytosis does not by itself establish which signaling pathway was activated. Cell identity, receptor stimulation, uptake and extracellular release are different experimental variables.

iC3b is a processed fragment of C3b formed through cleavage by complement factor I with a suitable partner such as complement factor H. It functions as an opsonin: deposition on a target supports recognition and uptake by phagocytes, including through complement receptor 3. ^[ref]

Processing does not simply erase every biological effect of the original protein. It changes the interactions available to the resulting fragment. In a 1983 experiment, cultured monocytes on appropriately coated surfaces showed complement-associated phagocytosis without the appreciable hydrogen peroxide release seen with the IgG-coated comparison.^[ref]

The comparison separates target uptake from an oxidative response. Measuring either alone would miss that separation; receptor engagement, ingestion and production of reactive substances are distinct experimental readouts. The older paper writes the fragment as C3bi; iC3b is the corresponding modern notation.

An opsonin is a substance that coats a target and promotes recognition and uptake by a phagocyte. The name describes a biological role: IgG and complement system fragments such as C3b and iC3b can supply different molecular handles for phagocytosis.^[ref]

A 1983 experiment separated uptake from another response. Cultured monocytes in contact with appropriate fibronectin-containing surfaces could ingest complement-coated targets without the substantial hydrogen peroxide release seen in the IgG comparison.^[ref]

Thus, coating, receptor engagement, phagocytosis and oxidant production are distinguishable steps. Calling a protein an opsonin does not imply that it digests the target itself, or that every receptor-triggered response accompanies uptake. A useful assay measures binding and internalization separately: a particle attached to a cell membrane is not necessarily inside the biological cell.

A phagocyte is a biological cell that takes up particles, such as bacteria or cell debris, by phagocytosis: the cell membrane encloses the material in an intracellular phagosome. Macrophages and neutrophils are important examples. The term describes an uptake capability, rather than a single developmental lineage. Contact with a particle, internalization and destruction of the ingested material are distinct events.

A useful experimental distinction is between phagocytosis and production of reactive oxygen compounds. S. D. Wright and S. C. Silverstein measured hydrogen peroxide released by human granulocytes, monocytes and macrophages spreading on surfaces coated with defined recognition molecules. Surfaces carrying IgG stimulated peroxide release, whereas surfaces carrying C3b or iC3b did not appreciably do so. Even when fibronectin supported a strong complement-receptor-associated phagocytic response in cultured monocytes, measurable peroxide release did not follow.^[ref]

For example, counting ten particle-containing phagosomes would establish uptake in the observed phagocyte; it would not count ten killed bacteria. A killing assay needs a further endpoint, such as recovery of viable organisms. Likewise, a low extracellular peroxide measurement alone does not establish absence of phagocytosis. Choosing an endpoint that matches the biological question is essential when comparing phagocytes.

S. D. Wright investigated how receptors of phagocytes connect recognition of coated targets with distinct cellular responses. With S. C. Silverstein, Wright compared hydrogen peroxide release from granulocytes, monocytes and macrophages spreading on surfaces coated with different ligands. The 1983 study found strong release on IgG-coated surfaces but little on surfaces carrying C3b or iC3b, historically written C3bi.^[ref]

The useful mechanistic distinction was between engulfment and an oxidative response. Under conditions combining fibronectin with complement ligands, the cultured monocytes showed a strong phagocytosis response without measurable hydrogen peroxide release.^[ref] Thus receptor engagement does not specify one indivisible activation state. Measuring only uptake would miss a difference revealed by measuring a second output.